Cargando…
Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic–mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer
The androgen receptor (AR) is an established orchestrator of cell metabolism in prostate cancer (PCa), notably by inducing an oxidative mitochondrial program. Intriguingly, AR regulates cytoplasmic isocitrate dehydrogenase 1 (IDH1), but not its mitochondrial counterparts IDH2 and IDH3. Here, we aime...
Autores principales: | Gonthier, Kevin, Weidmann, Cindy, Berthiaume, Line, Jobin, Cynthia, Lacouture, Aurélie, Lafront, Camille, Harvey, Mario, Neveu, Bertrand, Loehr, Jérémy, Bergeron, Alain, Fradet, Yves, Lacombe, Louis, Riopel, Julie, Latulippe, Éva, Atallah, Chantal, Shum, Michael, Lambert, Jean‐Philippe, Pouliot, Frédéric, Pelletier, Martin, Audet‐Walsh, Étienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552900/ https://www.ncbi.nlm.nih.gov/pubmed/37086156 http://dx.doi.org/10.1002/1878-0261.13441 |
Ejemplares similares
-
Multiple metabolic pathways fuel the truncated tricarboxylic acid cycle of the prostate to sustain constant citrate production and secretion
por: Frégeau-Proulx, Lilianne, et al.
Publicado: (2022) -
A FACS-Free Purification Method to Study Estrogen Signaling, Organoid Formation, and Metabolic Reprogramming in Mammary Epithelial Cells
por: Lacouture, Aurélie, et al.
Publicado: (2021) -
A Systematic Study of the Impact of Estrogens and Selective Estrogen Receptor Modulators on Prostate Cancer Cell Proliferation
por: Lafront, Camille, et al.
Publicado: (2020) -
FACS-Free isolation and purification protocol of mouse prostate epithelial cells for organoid primary culture
por: Frégeau-Proulx, Lilianne, et al.
Publicado: (2022) -
Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor‐associated macrophage phenotype
por: Boibessot, Clovis, et al.
Publicado: (2022)